STOCK TITAN

Empower, a CareCloud Company, Helps Wound-Care Provider Reverse More Than $1 Million in Alleged Overpayments

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

CareCloud (Nasdaq: CCLD) reported that Empower, its compliance business, supported a successful Medicare appeal reversing over $1 million in alleged overpayments for an experienced wound-care provider. An Administrative Law Judge ruled the advanced wound-care services were medically reasonable, necessary, and properly billed.

The case highlights Empower’s certified coding and documentation analysis, CareCloud’s AI-powered revenue cycle solutions used by over 45,000 providers, and aligns with CareCloud’s acquisition of Empower Healthcare & Compliance Partners, which closed on May 22, 2026.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • ALJ reversed over $1 million in alleged Medicare overpayments
  • Validates Empower’s certified coding and documentation audit-defense capabilities
  • Supports strategy behind Empower acquisition closed May 22, 2026
  • Leverages CareCloud’s AI revenue cycle tools used by 45,000+ providers

Negative

  • None.

News Market Reaction – CCLD

+0.64%
1 alert
+0.64% News Effect

On the day this news was published, CCLD gained 0.64%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Reversed overpayments: more than $1 million Providers served: more than 45,000 providers
2 metrics
Reversed overpayments more than $1 million Medicare appeal for wound-care provider
Providers served more than 45,000 providers CareCloud clients using its solutions

Market Reality Check

Price: $2.37 Vol: Volume 219,567 is 0.36x t...
low vol
$2.37 Last Close
Volume Volume 219,567 is 0.36x the 20-day average 610,951, suggesting limited pre-news positioning. low
Technical Shares trade below the 200-day MA, with price at 2.35 versus MA 3.01, indicating a prior downtrend.

Peers on Argus

CCLD fell 2.08% while close peers were mixed: HCAT and AMWL down, SOPH and LFMD ...

CCLD fell 2.08% while close peers were mixed: HCAT and AMWL down, SOPH and LFMD up, and MNDR sharply lower. The lack of a uniform move points to stock-specific factors rather than a sector-wide driver.

Historical Context

5 past events · Latest: May 26 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 26 Empower acquisition Positive -3.1% Acquired Empower compliance business to add recurring revenue and cross-selling.
May 21 Analyst Day themes Positive +0.8% Outlined AI-first model, cleaner equity, free cash flow growth and M&A engine.
May 18 Preferred redemption Positive +0.5% Redeemed Series B preferred using credit facility, simplifying capital structure.
May 11 Analyst Day announcement Positive -4.7% Announced Nasdaq bell ringing and 2026 Analyst Day, plus credit facility details.
May 07 Q1 2026 earnings Positive -17.4% Reported revenue growth, positive GAAP income, and reaffirmed 2026 guidance.
Pattern Detected

Recent positive strategic and financial updates have often been met with weak or negative price reactions.

Recent Company History

Over the past month, CareCloud reported Q1 2026 growth (revenue $31.3M, up 13% YoY) and reaffirmed full-year guidance, redeemed all Series B preferred stock via a $50M facility, and outlined an AI-first, acquisition-driven model at its Analyst Day. It also acquired Empower Healthcare & Compliance Partners, adding a compliance business. Despite largely constructive news on growth, capital structure, and AI strategy, several of these announcements were followed by share price declines.

Market Pulse Summary

This announcement highlights a successful Medicare appeal in which Empower helped reverse more than ...
Analysis

This announcement highlights a successful Medicare appeal in which Empower helped reverse more than $1 million in alleged overpayments tied to advanced wound care. It underscores CareCloud’s strategy of pairing AI-enabled revenue cycle tools with deep compliance expertise, following its acquisition of Empower. Investors may watch for additional case wins, evidence of broader adoption across the more than 45,000 providers on the platform, and any financial disclosures quantifying this business line.

Key Terms

office of medicare hearings and appeals, administrative law judge, unified program integrity contractor, medicare administrative contractor, +3 more
7 terms
office of medicare hearings and appeals regulatory
"successful audit defense before the Office of Medicare Hearings and Appeals"
A federal administrative office that acts like a small claims court for disputes over Medicare coverage and payments, where providers, suppliers, and beneficiaries appeal denied claims or reimbursement decisions. Investors care because its rulings can change how much and how quickly healthcare companies get paid by Medicare, affecting revenue, cash flow and the financial risk of providers that rely on government payments.
administrative law judge regulatory
"The Administrative Law Judge (“ALJ”) found that the disputed services were"
An administrative law judge is a government-employed judge who hears and decides disputes inside federal or state regulatory agencies, such as enforcement actions, licensing questions, benefit claims, or compliance disputes. Their decisions can impose fines, block approvals, or require business changes, so investors treat them like a referee whose calls can directly affect a company’s costs, operations, legal risk, or ability to sell products.
unified program integrity contractor regulatory
"a Unified Program Integrity Contractor (“UPIC”) alleged significant overpayments"
A unified program integrity contractor is a government-hired firm that hunts down fraud, waste and abuse across public healthcare programs by combining several oversight roles into one team. Think of it as a single neighborhood watch that replaces multiple patrols to spot suspicious billing, prevent improper payments and recover money. Investors care because these contractors influence enforcement actions, payment delays and audits that can affect healthcare providers’ revenue and the sales of vendors that serve them.
medicare administrative contractor regulatory
"carried forward at the Medicare Administrative Contractor (“MAC”) and Qualified"
A Medicare Administrative Contractor is a private company hired to handle billing, payments, provider enrollment, and routine audits for Medicare in a specific region, acting like a local claims processor for a large government health plan. Investors care because these contractors influence how quickly and accurately healthcare providers get reimbursed, which affects providers’ cash flow, revenue timing and audit risk—key drivers of financial stability for companies that rely on Medicare payments.
qualified independent contractor regulatory
"Administrative Contractor (“MAC”) and Qualified Independent Contractor (“QIC”)"
A qualified independent contractor is an outside professional or firm that has the required credentials, licenses or approvals to perform a specific task and is not employed by or tied to the company hiring them. Investors care because using an independent specialist reduces conflicts of interest and increases trust in reports, audits, or technical opinions—think of them as a neutral referee whose findings help investors judge the company’s claims and compliance.
cpt codes medical
"application services including CPT codes 15271 and 15272"
CPT codes are standardized five-digit codes used to describe medical procedures, tests and services for billing, insurance reimbursement and data tracking. Think of them like barcodes for healthcare services: they tell payers what was done and influence how much providers get paid. Investors watch CPT codes because changes in coding, coverage or reimbursement rates can materially affect a healthcare provider’s revenue, equipment manufacturers’ sales and overall adoption of new treatments.
cms regulatory
"Q code for a cellular and/or tissue-based product billed to CMS, along with"
The Centers for Medicare & Medicaid Services (CMS) is the U.S. federal agency that sets rules, payment rates and coverage decisions for major public health insurance programs; think of it as both a giant insurer and the rulebook maker for how many healthcare providers and drug makers get paid by government programs. Its policy changes and reimbursement decisions can materially affect revenue, profit forecasts and valuations for hospitals, insurers, device makers and drug companies, so investors watch CMS announcements closely.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Certified coding and documentation expertise proves decisive in successful audit defense before the Office of Medicare Hearings and Appeals

SOMERSET, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its compliance business, Empower Healthcare and Compliance (“Empower”), provided the certified coding and documentation analysis that supported a successful Medicare appeal reversing more than $1 million in alleged overpayments tied to advanced wound-care products and application services. The Administrative Law Judge (“ALJ”) found that the disputed services were medically reasonable and necessary and properly billed under Medicare rules.

“This outcome reflects what disciplined, claim-by-claim coding analysis can accomplish in a high-dollar audit,” said Mitchell Brie, CHC, President of Empower at CareCloud. “When the coding, documentation, and clinical record are aligned with Medicare policy and presented clearly, even substantial post-payment findings can be overturned. This case is representative of the type of audit defense work our team performs nationwide, particularly in complex wound-care and skin substitute audits. We were also privileged to work alongside Guillermo J. Beades, Esq., of Frier Levitt, whose leadership of the appeal helped present a compelling case before the ALJ. It is exactly the kind of collaborative effort between legal, clinical, and coding experts that gives providers the analysis, knowledge, and confidence to defend their claims.”

“This result demonstrates the value of combining compliance expertise with technology-enabled revenue cycle solutions,” said Stephen Snyder, Chief Executive Officer of CareCloud. “Providers are facing increasing audit activity and reimbursement pressure from both government and commercial payers. Through Empower, we are expanding our ability to help healthcare organizations protect revenue, defend appropriately billed claims, and strengthen financial performance across the reimbursement lifecycle.”

The matter arose from a post-payment audit in which a Unified Program Integrity Contractor (“UPIC”) alleged significant overpayments against an experienced wound-care provider. The disputed claims involved a Q code for a cellular and/or tissue-based product billed to CMS, along with associated application services including CPT codes 15271 and 15272. The contractor challenged coverage, medical necessity, and coding — a pattern increasingly common in advanced wound-care audits — with the findings carried forward at the Medicare Administrative Contractor (“MAC”) and Qualified Independent Contractor (“QIC”) levels.

Empower’s role centered on rebuilding the coding and documentation record on a claim-by-claim basis. Empower’s certified coding expert analyzed code selection, modifiers, units, documentation sufficiency, and product reporting, then translated those complex billing and documentation issues into clear, plain-language terms for the ALJ. That analysis aligned the clinical documentation, operative and progress notes, and product records with applicable Medicare policy to demonstrate that each disputed date of service met the agency’s “reasonable and necessary” standard and supported the ALJ’s ruling and reversal of more than $1 million in alleged overpayments.

This success reflects the strategy behind CareCloud’s acquisition of Empower Healthcare & Compliance Partners, LLC, which closed on May 22, 2026. By pairing Empower’s compliance expertise with CareCloud’s AI-powered technology and revenue cycle management solutions — relied on by more than 45,000 providers — the combined company is uniting revenue integrity and audit defense so providers keep more of what they have rightfully earned.

About Empower

Empower is a full-service healthcare compliance and advisory firm trusted by providers and healthcare organizations nationwide. Founded by Mitchell Brie, CHC, Empower helps medical practices and health systems navigate an increasingly complex regulatory landscape through services spanning compliance and ethics, privacy and security, revenue integrity, and merger and acquisition support. The firm is known for its proactive, education-first approach to audit defense, risk mitigation, and regulatory readiness. Empower was acquired by CareCloud, Inc. on May 22, 2026, and now operates as a CareCloud company.

About CareCloud

CareCloud brings disciplined innovation to the business of healthcare. The Company’s suite of AI and technology-enabled solutions helps healthcare organizations increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers rely on CareCloud’s solutions and services across revenue cycle management, practice management, electronic health records, patient experience management, business intelligence and digital health.

Follow CareCloud on LinkedIn, X and Facebook.

For additional information, please visit carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

Forward-Looking Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations, or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Forward-looking statements in this press release include, without limitation, statements regarding the expected benefits of the acquisition of Empower Healthcare & Compliance Partners, LLC, the integration of Empower’s operations and personnel, the anticipated immaterial financial impact of the transaction, the expected growth and cross-selling opportunities arising from the acquisition, the Company’s ability to offer compliance services to its providers, and the Company’s acquisition strategy, growth, profitability, and AI initiatives. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain, and involve substantial known and unknown risks, uncertainties, and other factors which may cause our (or our industry’s) actual results, levels of activity, or performance to be materially different from any future results, levels of activity, or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, integrate newly acquired businesses and retain new and existing customers, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE: CareCloud

Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com

Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com


FAQ

What did CareCloud (NASDAQ: CCLD) announce about reversing over $1 million in Medicare alleged overpayments?

CareCloud announced that Empower helped overturn more than $1 million in alleged Medicare overpayments for a wound-care provider. According to CareCloud, an Administrative Law Judge found the advanced wound-care services medically reasonable, necessary, and properly billed after detailed claim-by-claim coding and documentation analysis.

How did Empower, a CareCloud company, assist a wound-care provider in the June 2026 Medicare audit appeal (CCLD)?

Empower provided certified coding and documentation analysis that supported a favorable Administrative Law Judge decision. According to CareCloud, Empower rebuilt each claim’s coding record, aligning clinical notes, product data, and Medicare policy to demonstrate medical necessity and appropriate billing for the disputed advanced wound-care services.

What does the Administrative Law Judge’s decision mean for CareCloud (CCLD) clients using Empower for audit defense?

The decision shows Empower’s approach can succeed in complex, high-dollar Medicare audits. According to CareCloud, combining legal, clinical, and coding expertise helped overturn extensive post-payment findings, suggesting Empower’s methods may help other providers defend appropriately billed claims and protect reimbursement revenue.

When did CareCloud complete the acquisition of Empower Healthcare & Compliance Partners, and why is it important for CCLD investors?

CareCloud completed the Empower acquisition on May 22, 2026. According to CareCloud, integrating Empower’s compliance and audit-defense expertise with its AI-powered revenue cycle platform aims to strengthen revenue integrity services and support financial performance for healthcare organizations using its technology.

How many providers use CareCloud’s AI-powered revenue cycle and compliance solutions after the Empower acquisition (CCLD)?

CareCloud reports that more than 45,000 providers rely on its technology and revenue cycle solutions. According to CareCloud, pairing this platform with Empower’s compliance and audit-defense capabilities is intended to help organizations protect revenue and defend claims across the full reimbursement lifecycle.

What Medicare billing codes were involved in the wound-care audit case highlighted by CareCloud (CCLD)?

The disputed claims involved a Q code for a cellular and/or tissue-based product and CPT codes 15271 and 15272. According to CareCloud, Empower’s expert examined code selection, modifiers, units, and documentation sufficiency to align the claims with applicable Medicare coverage policy.